StockData
Spruce Biosciences, Inc. logo

Spruce Biosciences, Inc. (SPRB) stock

SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$43.31+0.42 (+0.98%)

Close on Nov 13, 2026Market cap $124.47MP/E –Yield –

Spruce Biosciences total assets

Total assets on the balance sheet at the end of each period.

Spruce Biosciences's total assets was $91.95M at Sep 30, 2026. For fiscal 2025 it was $53.02M, up 17.3% from the year before. The highest annual figure on record is $162.88M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$53.02M+17.3%
FY2024Dec 31, 2024$45.21M-56.5%
FY2023Dec 31, 2023$103.95M+21.4%
FY2022Dec 31, 2022$85.65M-32.3%
FY2021Dec 31, 2021$126.49M-22.3%
FY2020Dec 31, 2020$162.88M+3371.5%
FY2019Dec 31, 2019$4.69M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$91.95M+500.5%
Q2 FY2026Jun 30, 2026$102.85M+371.4%
Q1 FY2026Mar 31, 2026$56.17M+77.5%
Q4 FY2025Dec 31, 2025$53.02M+17.3%
Q3 FY2025Sep 30, 2025$15.31M-76.5%
Q2 FY2025Jun 30, 2025$21.82M-71.1%
Q1 FY2025Mar 31, 2025$31.65M-63.8%
Q4 FY2024Dec 31, 2024$45.21M-56.5%
Q3 FY2024Sep 30, 2024$65.10M-42.4%
Q2 FY2024Jun 30, 2024$75.52M-40.0%
Q1 FY2024Mar 31, 2024$87.54M-37.1%
Q4 FY2023Dec 31, 2023$103.95M+21.4%
Q3 FY2023Sep 30, 2023$112.99M+18.6%
Q2 FY2023Jun 30, 2023$125.96M+20.5%
Q1 FY2023Mar 31, 2023$139.11M+21.0%
Q4 FY2022Dec 31, 2022$85.65M-32.3%
Q3 FY2022Sep 30, 2022$95.30M-29.5%
Q2 FY2022Jun 30, 2022$104.52M-27.1%
Q1 FY2022Mar 31, 2022$114.99M-25.3%
Q4 FY2021Dec 31, 2021$126.49M-22.3%
Q3 FY2021Sep 30, 2021$135.09M+72.1%
Q2 FY2021Jun 30, 2021$143.45M+2957.3%
Q1 FY2021Mar 31, 2021$153.99M–
Q4 FY2020Dec 31, 2020$162.88M–
Q3 FY2020Sep 30, 2020$78.49M–
Q4 FY2019Dec 31, 2019$4.69M–

More Spruce Biosciences figures

See a number that looks wrong?